Harlin H - Search Results

1

Immune suppression in the tumor microenvironment.

Gajewski TF, Meng Y, Harlin H. Gajewski TF, et al. Among authors: harlin h. J Immunother. 2006 May-Jun;29(3):233-40. doi: 10.1097/01.cji.0000199193.29048.56. J Immunother. 2006. PMID: 16699366 Review.

2

Immune resistance orchestrated by the tumor microenvironment.

Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Gajewski TF, et al. Among authors: harlin h. Immunol Rev. 2006 Oct;213:131-45. doi: 10.1111/j.1600-065X.2006.00442.x. Immunol Rev. 2006. PMID: 16972901 Review.

3

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.

Peterson AC, Harlin H, Gajewski TF. Peterson AC, et al. Among authors: harlin h. J Clin Oncol. 2003 Jun 15;21(12):2342-8. doi: 10.1200/JCO.2003.12.144. J Clin Oncol. 2003. PMID: 12805336 Clinical Trial.

4

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF. Harlin H, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1185-97. doi: 10.1007/s00262-005-0118-2. Epub 2006 Feb 9. Cancer Immunol Immunother. 2006. PMID: 16468035 Free PMC article.

5

Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.

Harlin H, Artz AS, Mahowald M, Rini BI, Zimmerman T, Vogelzang NJ, Gajewski TF. Harlin H, et al. Bone Marrow Transplant. 2004 Mar;33(5):491-7. doi: 10.1038/sj.bmt.1704385. Bone Marrow Transplant. 2004. PMID: 14716341 Clinical Trial.

6

Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.

Meng Y, Harlin H, O'Keefe JP, Gajewski TF. Meng Y, et al. Among authors: harlin h. J Immunol. 2006 Aug 1;177(3):1981-7. doi: 10.4049/jimmunol.177.3.1981. J Immunol. 2006. PMID: 16849512

7

The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.

Knight D, Peterson AC, Rini BI, Harlin H, Gajewski TF, Stadler WM. Knight D, et al. Among authors: harlin h. Prostate. 2009 Feb 1;69(2):142-8. doi: 10.1002/pros.20864. Prostate. 2009. PMID: 18942640

8

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Harlin H, et al. Cancer Res. 2009 Apr 1;69(7):3077-85. doi: 10.1158/0008-5472.CAN-08-2281. Epub 2009 Mar 17. Cancer Res. 2009. PMID: 19293190 Free PMC article.

9

Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines.

Tschoep K, Manning TC, Harlin H, George C, Johnson M, Gajewski TF. Tschoep K, et al. Among authors: harlin h. J Leukoc Biol. 2003 Jul;74(1):69-80. doi: 10.1189/jlb.0702352. J Leukoc Biol. 2003. PMID: 12832444

10

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.

Peterson AC, Harlin H, Karrison T, Vogelzang NJ, Knost JA, Kugler JW, Lester E, Vokes E, Gajewski TF, Stadler WM; University of Chicago Phase II Consortium. Peterson AC, et al. Among authors: harlin h. Invest New Drugs. 2006 Mar;24(2):141-9. doi: 10.1007/s10637-006-5935-4. Invest New Drugs. 2006. PMID: 16514482 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters